novo nordisk glp-1 weight loss glp 1 drugs Novo Nordisk's weight-loss pill wins FDA approval-revival-foundation.org Novo Nordisk's Oral GLP-1 Wegovy

Once Novo Nordisk's patent expires, about 50 generic semaglutide brands are expected to enter India alone, some as soon as this weekend.

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

If you're taking a GLP-1, you may not want to take it forever

Method: This is a multi-centre, randomised, double-blind, placebo-controlled, phase IIb trial of liraglutide in participants with mild to moderate Alzheimers

Rosen, MD, and Julie Ingelfinger, MD, from Tufts University School of Medicine and the Maine Medical Center Institute for Research (MaineHealth):

Check out our story here with the...